Format

Send to

Choose Destination
J Clin Apher. 2018 Feb;33(1):78-94. doi: 10.1002/jca.21562. Epub 2017 Jun 27.

Critical updates in the 7th edition of the American Society for Apheresis guidelines.

Author information

1
Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas.
2
Department of Pathology, Division of Laboratory Medicine, University of Alabama, Birmingham, Alabama.

Abstract

The 7th edition of the American Society for Apheresis (ASFA) guidelines was composed by an international physicians committee, and includes 14 new diseases, and 2 new indications for diseases described in the former guidelines. Several indications have either changed names or were excluded from this edition. The guidelines are developed after taking into account documented evidence, either supporting or negating use of apheresis technology in the treatment of diseases. Based on this evidence, the committee revises, updates and includes or excludes disease entities/indications in the guidelines. This article describes the revisions to the 7th edition of the ASFA guidelines, in a comprehensive manner.

KEYWORDS:

7th edition; ASFA guidelines; apheresis; critical updates; diseases and indications

PMID:
28653762
DOI:
10.1002/jca.21562
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center